We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

A recipient of the 2025 Elite Trial Lawyers Lifetime Achievement Award, Morgan & Morgan's John Yanchunis spoke with the National Law Journal about his storied career, from bringing one of the nation’s ...

In just a few years, weight-loss drugs like Ozempic and Wegovy have become a global sensation. They promise to do something ...

Explore daily insights on the USA TODAY crossword puzzle by . Uncover expert takes and answers in our crossword blog.

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

GLP-1 drugs came out in 2005 as a Type 2 diabetes treatment. But in recent years their popularity for weight loss -- and the cost -- has taken off.

Find the answer for Org. that regulates Ozempic from the people who brought you the USA TODAY Daily Crossword Puzzle.

More than 1% of U.S. children between the ages of 2 and 18 had “extremely severe obesity” in 2023 — a 250% increase from 2008 ...

A Minnesota state senator convicted of burglary for breaking into her estranged stepmother’s house plans to resign by early ...

Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation for continued carePresentations on tau to explore its biological role, the d ...

Scientists use a precise form of gene editing called prime editing to correct the most common genetic mutations that cause alternating hemiplegia of childhood, a rare and severe neurological disorder ...